Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/IOVS.06-0450PMID 17065516PMCID PMC1828044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis.

  2006cited by this paper
• Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells

  2006cited by this paper
• Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.

  2006cited by this paper
• Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

  2005cited by this paper
• Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema

  2005cited by this paper
• Triamcinolone acetonide destabilizes VEGF mRNA in Müller cells under continuous cobalt stimulation.

  2005cited by this paper
• Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress.

  2005cited by this paper
• Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo

  2005cited by this paper
• Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use

  2005cited by this paper
• DIFFERENCE IN CLEARANCE OF INTRAVITREAL TRIAMCINOLONE ACETONIDE BETWEEN VITRECTOMIZED AND NONVITRECTOMIZED EYES

  2005cited by this paper
• It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE study.

  2005cited by this paper
• Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

  2004cited by this paper
• A central role for inflammation in the pathogenesis of diabetic retinopathy

  2004cited by this paper
• INTRAVITREAL TOXICITY OF THE KENALOG VEHICLE (BENZYL ALCOHOL) IN RABBITS

  2004cited by this paper
• Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.

  2004cited by this paper
• INTRAVITREAL CONCENTRATION AND CLEARANCE OF TRIAMCINOLONE ACETONIDE IN NONVITRECTOMIZED HUMAN EYES

  2004cited by this paper
• Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-a, vascular endothelial growth factor and platelet-derived growth factor

  2004cited by this paper
• Serum levels of triamcinolone acetonide after intravitreal injection.

  2004cited by this paper
• Ocular Pharmacokinetics of Fluocinolone Acetonide After Retisert™ Intravitreal Implantation in Rabbits Over a 1-Year Period

  2004cited by this paper
• VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.

  2004cited by this paper
• Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.

  2004cited by this paper
• Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

  2003cited by this paper
• Effect of Dexamethasone Treatment on Serum GH, IGF-I, and the Binding Proteins IGFBP-1 and -3 in Ventilated Very Preterm Infants

  2003cited by this paper
• Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial.

  2003cited by this paper
• Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.

  2003cited by this paper
• Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease

  2003cited by this paper
• IGF-I is critical for normal vascularization of the human retina.

  2002cited by this paper
• Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.

  2002cited by this paper
• Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.

  2002cited by this paper
• A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.

  2001cited by this paper
• Growth restriction in dexamethasone‐treated preterm infants may be mediated by reduced IGF‐I and IGFBP‐3 plasma concentrations

  2001cited by this paper
• Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

  2001cited by this paper
• RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN–6 IN DIABETIC RETINOPATHY

  2001cited by this paper
• Neovascularization grading methods in a rat model of retinopathy of prematurity.

  2000cited by this paper
• Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone.

  2000cited by this paper
• Role of intravitreal dexamethasone in exogenous fungal endophthalmitis

  1999cited by this paper
• Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity.

  1998cited by this paper
• Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity.

  1997cited by this paper
• Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.

  1997cited by this paper
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Glial, vascular, and neuronal cytogenesis in whole‐mounted cat retina

  1997cited by this paper
• Transcutaneous oxygen levels in retinopathy of prematurity.

  1995cited by this paper
• The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats.

  1995cited by this paper
• Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Effects of steroids on diaphragmatic function in rats.

  1990cited by this paper
• Effects of sepsis on diaphragmatic function in rats.

  1988cited by this paper
• Neovascularisation associated with posterior uveitis.

  1987cited by this paper
• Effect of Oxygen on Developing Retinal Vessels with Particular Reference to the Problem of Retrolental Fibroplasia

  1954cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

  2024cites this paper
• Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity

  2023cites this paper
• Subcutaneous nodules at progesterone injection sites after fertility treatment

  2018cites this paper
• Improvement of alopecia areata with apremilast

  2018cites this paper
• Glucocorticoids exert direct toxicity on microvasculature: analysis of cell death mechanisms.

  2015cites this paper
• Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema.

  2014cites this paper
• SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.

  2013cites this paper
• Etude de la toxicité et des mécanismes de mort cellulaire induits par les glucocorticoïdes sur les cellules endothéliales

  2013cites this paper
• Disruption of IAP/SHPS-1 association inhibits pathophysiologic changes in retinal endothelial function in diabetic rats

  2013cites this paper
• Triamcinolone Acetonide Prevents Enhancement of Hypoxia-induced Neuronal and Inducible Nitric Oxide Synthases in the Retinas of Rats with Oxygen-induced Retinopathy

  2012cites this paper
• Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes

  2012cites this paper
• VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.

  2012cites this paper
• The influence of triamcinolone on endostatin-like proteins in oxygen-induced retinopathy of prematurity.

  2012cites this paper
• Effect of Ethylene Diurea on Oxygen-induced Ischemic Retinopathy in the Neonatal Rat

  2010cites this paper
• Chapter 72 – Retinopathy of prematurity

  2010cites this paper
• Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

  2010cites this paper
• The in vitro response of human retinal endothelial cells to cytokines and other chemically active agents is altered by coculture with vitreous‐derived hyalocytes

  2010cites this paper
• Large fat and skin necroses after deep subcutaneous injections of a slow-release somatostatin analogue in a woman with acromegaly.

  2010cites this paper
• Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.

  2010influential citation
• Intraocular Pressure Changes in Eyes Receiving Intravitreal Triamcinolone Acetonide in Kikuyu Eye Unit

  2009cites this paper
• The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.

  2009cites this paper
• Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.

  2009cites this paper
• [Retinopathy of prematurity. Prevention, screening and treatment guidelines].

  2009cites this paper
• Effects of triamcinolone acetonide on vessels of the posterior segment of the eye

  2009cites this paper
• Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity

  2008cites this paper
• Update on the Treatment of Diabetic Retinopathy

  2008cites this paper
• Comprehensive gene-expression profile in murine oxygen-induced retinopathy

  2008cites this paper
• Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi

  2008cites this paper
• Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization

  2008cites this paper
• Late postnatal systemic steroids predispose to retinopathy of prematurity in very‐low‐birth‐weight infants: a comparative study

  2008cites this paper
• Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

  2008cites this paper
• Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity

  2007cites this paper
• Exploring the molecular mechanism of ocular angiogenesis inhibition by triamcinolone acetonide

  2007cites this paper
• An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.

  2007cites this paper